We are live on ! Find out more
FO

FT Options Portfolio holdings

AUM $66.4M
1-Year Est. Return 18.48%
This Fund
S&P 500
This Quarter Est. Return
-1.61%
1 Year Est. Return
+18.48%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$116M
AUM Growth
+$21M
Cap. Flow
+$284M
Cap. Flow %
244.1%
Top 10 Hldgs %
42.12%
Holding
462
New
171
Increased
79
Reduced
68
Closed
122

Top Buys

1
MDVN
MEDIVATION, INC.
MDVN
+$4.59M
2
BIIB icon
Biogen
BIIB
+$3.56M
3
CALM icon
Cal-Maine
CALM
+$2.79M
4
BMY icon
Bristol-Myers Squibb
BMY
+$2.48M
5
AAPL icon
Apple
AAPL
+$2.33M

Top Sells

1
BAX icon
Baxter International
BAX
+$4.11M
2
GILD icon
Gilead Sciences
GILD
+$2M
3
IBM icon
IBM
IBM
+$1.48M
4
CMG icon
Chipotle Mexican Grill
CMG
+$930K
5
EXPE icon
Expedia Group
EXPE
+$914K

Sector Composition

1 Healthcare 41.4%
2 Technology 6.27%
3 Consumer Staples 4.14%
4 Consumer Discretionary 2.26%
5 Materials 1.61%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BA icon
351
PUT
Boeing
BA
$169B
– –
-5,000
Closed -$11K
BAX icon
352
Baxter International
BAX
$11.7B
– –
-100,000
Closed -$4.11M
BAX icon
353
PUT
Baxter International
BAX
$11.7B
– –
-100,000
Closed -$1.42M
CAG icon
354
CALL
Conagra Brands
CAG
$6.83B
– –
-28,913
Closed -$40K
CDNS icon
355
PUT
Cadence Design Systems
CDNS
$91B
– –
-25,000
Closed -$4K
CLX icon
356
PUT
Clorox
CLX
$11.6B
– –
-5,000
Closed -$5K
CMG icon
357
CALL
Chipotle Mexican Grill
CMG
$44.2B
– –
-385,000
Closed -$147K
CMG icon
358
Chipotle Mexican Grill
CMG
$44.2B
– –
-98,700
Closed -$930K
CMG icon
359
PUT
Chipotle Mexican Grill
CMG
$44.2B
– –
-225,000
Closed -$211K
VISN
360
CALL
Vistance Networks Inc
VISN
$2.74B
– –
-17,600
Closed -$36K
CTSH icon
361
CALL
Cognizant
CTSH
$21.2B
– –
-10,400
Closed -$15K
EA icon
362
CALL
Electronic Arts
EA
$52.4B
– –
-61,000
Closed -$140K
EA icon
363
PUT
Electronic Arts
EA
$52.4B
– –
-59,900
Closed -$68K
EFA icon
364
CALL
iShares MSCI EAFE ETF
EFA
$76.5B
– –
-100,000
Closed -$38K
EW icon
365
CALL
Edwards Lifesciences
EW
$49.4B
– –
-157,500
Closed -$207K
EW icon
366
PUT
Edwards Lifesciences
EW
$49.4B
– –
-21,000
Closed -$13K
EXPE icon
367
Expedia Group
EXPE
$32.3B
– –
-8,481
Closed -$914K
EXPE icon
368
PUT
Expedia Group
EXPE
$32.3B
– –
-10,000
Closed -$76K
FOLD
369
CALL
DELISTED
Amicus Therapeutics
FOLD
– –
-20,400
Closed -$34K
FOLD
370
PUT
DELISTED
Amicus Therapeutics
FOLD
– –
-25,000
Closed -$9K
GLW icon
371
CALL
Corning
GLW
$133B
– –
-73,400
Closed -$91K
GLW icon
372
PUT
Corning
GLW
$133B
– –
-47,400
Closed -$14K
GMED icon
373
PUT
Globus Medical
GMED
$10.5B
– –
-20,000
Closed -$11K
GOOG icon
374
CALL
Alphabet (Google) Class C
GOOG
$4.22T
– –
-60,000
Closed -$102K
GOOG icon
375
Alphabet (Google) Class C
GOOG
$4.22T
– –
-3,600
Closed -$134K
13 14
15
16 17

Similar funds

MC
Micawber Capital Seattle, Washington $62.9M AUM 20.32% 1-Year Est. Return
FIM
Friedberg Investment Management Houston, Texas $61.9M AUM 20.07% 1-Year Est. Return
TLIC
Thai Life Insurance Company Bangkok, Thailand $71M AUM 20.14% 1-Year Est. Return
MKCM
Mount Kellett Capital Management New York $61M AUM 12.22% 1-Year Est. Return
ACM
Americafirst Capital Management Roseville, California $74M AUM 13.49% 1-Year Est. Return
MFM
Marianas Fund Management New York $58.1M AUM 10.84% 1-Year Est. Return
VE
Vega Energy New York $75.5M AUM 15.36% 1-Year Est. Return
GFWEV
G.F.W. Energy VIII Irving, Texas $76.3M AUM 11.41% 1-Year Est. Return

FT Options's Q2 2016 Portfolio in Review

As of Q2 2016, FT Options held 462 positions worth $116M, up 22% from $95.5M the previous quarter. Its ten largest holdings account for 42% of the portfolio.

FT Options deployed $284M of net new capital in Q2 2016, opening 171 new positions and adding to 79 existing holdings. Its largest new stake was Bristol-Myers Squibb: 35,075 shares worth $2.58M.

By sector, the portfolio is most concentrated in Healthcare at 41% of assets, down from 48% a quarter earlier, followed by Technology and Consumer Staples.

On the sell side, the largest reduction was Gilead Sciences, an estimated $2M trimmed.

  • FT Options's largest Q2 2016 buy was Bristol-Myers Squibb: 35,075 shares worth $2.58M.
  • FT Options added most to MEDIVATION, INC. in Q2 2016, an estimated $4.59M increase.
  • FT Options's biggest Q2 2016 reduction was Gilead Sciences, cutting an estimated $2M.
  • FT Options fully exited Baxter International in Q2 2016, selling an estimated $4.11M.
  • FT Options's ten largest holdings make up 42% of its $116M portfolio in Q2 2016.
  • FT Options opened 171 new positions and closed 122 in Q2 2016.
  • FT Options's portfolio value rose 22% quarter-over-quarter to $116M.

Based on FT Options's 13F filing for Q2 2016, filed 12 Aug 2016.